About RAMM Pharma
RAMM Pharma is a company based in Toronto (Canada) founded in 1988. It operates as a Direct-to-Consumer (D2C) and B2B2C. RAMM Pharma offers products and services including Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti. RAMM Pharma operates in a competitive market with competitors including Decibel Cannabis, Protonify and Siam Stix Ventures, among others.
- Headquarter Toronto, Canada
- Stage Public
- SectorsHealthcare
- Website wearerammpharma.com
- Social LinkedIn
- Legal Name Ramm Pharma Corp
- Annual Revenue$2.4 M (USD)-22.6as on Oct 31, 2025
- Net Profit-$6.35 M (USD)46.01as on Oct 31, 2025
- EBITDA-$2.69 M (USD)31.7as on Oct 31, 2025
Products & Services of RAMM Pharma
RAMM Pharma offers a comprehensive portfolio of products and services, including Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti.
Cannabidiol-based pharmaceutical product for oral sublingual use.
Pure cannabidiol pharmaceutical for oral sublingual application.
Cannabidiol-based solution for dogs with therapeutic effects.
Balanced pet food for various life stages.
Natural cosmetic products respecting nature and environment.
Funding Insights of RAMM Pharma
- Total Rounds 1
All 1 funding rounds of RAMM Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | – | Post-IPO | – | – | – |
People of RAMM Pharma
1 people are tracked at RAMM Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jack Burnett | CEO | Leadership |
Complete people profiles for RAMM Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of RAMM Pharma
RAMM Pharma is a publicly listed company on the CSE with ticker symbol RAMM in Canada, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Nov 2019
- Listed onCSE: RAMM
- Listed entityRamm Pharma Corp
- Exchange sectorConsumer non-durables
- ISINCA75150G1046
- Share price0.01 CAD (-50% on the day) · 2026-10-08
- Market capitalisation596,947.00 CAD
- EPS (diluted, trailing year)-0.08 CAD
- Volume (last session)93,000
Financials of RAMM Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3.4M CAD | -8.9M CAD | -3.8M CAD |
| 2024 | 4.3M CAD | -16.5M CAD | -5.5M CAD |
| 2023 | 5.1M CAD | -7.7M CAD | -5.7M CAD |
| 2022 | 3.9M CAD | -21.0M CAD | -6.9M CAD |
| 2021 | 4.1M CAD | -7.1M CAD | -5.9M CAD |
Detailed financial statements for RAMM Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of RAMM Pharma
3 dated milestones of RAMM Pharma across 35 years, from founding to its latest funding, stage changes and deals.
- Founded RAMM Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
Competitors of RAMM Pharma
RAMM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Decibel Cannabis, Protonify and Siam Stix Ventures, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| decibelcc.com | 2008 | Calgary, Canada | – | 49 | Cannabis products are produced and distributed by Decibel Cannabis. | |
| protonify.com | 2017 | Nanoose Bay, Canada | – | 9 | Production and distribution of biological cannabinoids are conducted. | |
| siamstixventures.com | 2022 | Vancouver, Canada | – | – | Serves as a contract manufacturer specializing in cannabis products. |
Detailed competitors of RAMM Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ramm Pharma
Complete news archive for RAMM Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to RAMM Pharma
10 companies that operate in the same segment as RAMM Pharma (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 137 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RAMM Pharma
RAMM Pharma was founded in 1988 and raised its 1st funding round 35 years after it was founded.
RAMM Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Jack Burnett is the current CEO of RAMM Pharma.
Annual revenue of RAMM Pharma is $2.4M as on Oct 31, 2025.
RAMM Pharma is involved in the development and distribution of cannabinoid-based pharmaceutical products approved by health authorities. Operations are primarily based in Uruguay, benefiting from the countrys stable political and economic environment. The company has established distribution agreements across Latin America, targeting a vast population. Products like Epifractán and Xalex are cultivated under strict quality norms. Additionally, subsidiaries like NettaLife focus on innovative pet care solutions, while Canapar in Sicily handles high-tech cannabis extraction for cosmetic, nutraceutical, and pharmaceutical sectors. Marishanti offers natural beauty products with an environmental focus.
RAMM Pharma's top competitors include Decibel Cannabis, Protonify and Siam Stix Ventures.
RAMM Pharma offers Epifractán, Xalex 10, Nettavet, Nettapet, and Marishanti.
Yes, RAMM Pharma is publicly traded on CSE under the ticker symbol RAMM.